Last reviewed · How we verify
NCT03064789
Epidemiological Study in Subjects With Vulvovaginal Candidiases
trial in Vulvovaginal Candidiases in 43 participants. Completed in 30 June 2019.
30 March 2019
Quick facts
| Lead sponsor | Dr. Santiago Palacios |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 43 |
| Start date | 29 December 2016 |
| Primary completion | 30 March 2019 |
| Estimated completion | 30 June 2019 |
| Sites | 1 location across Spain |
Conditions studied
- Vulvovaginal Candidiases — all drugs for Vulvovaginal Candidiases →
Sponsor
Dr. Santiago Palacios
Who can join
Adults 18 to 50, female only, with Vulvovaginal Candidiases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Epidemiological study about the clinical and microbiological progress in subjects under treatment for a severe vulvovaginal candidiases episody
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03064789
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Dr. Santiago Palacios trials
Trials by the same sponsor.
- NCT04898556 — Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vu · Phase 3 · unknown
- NCT03438422 — Effect of Pollen Extract on Urinary Incontinence · Phase 3 · completed
- NCT03429231 — Observational Study to Evaluate the Quality of Life of Healthy Postmenopausal Women Who Take Coenzyme Q-Ubiquinol · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03064789 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr. Santiago Palacios
- Last refreshed: 11 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03064789.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing